Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Succinylcholine vs Rocuronium for Prehospital Emergency Intubation
NCT02000674Phase 3Completed
- Sponsor
- CHU de La Réunion
- Start
- Dec 2013
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of rocuronium in coma, Major trauma, respiratory distress syndrome (RDS) and 1 more, sponsored by CHU de La Réunion. Primary endpoint: First-pass intubation success rate. Started Dec 2013; status: completed.
02
Drugs
rocuronium
03
Conditions
comaMajor traumarespiratory distress syndrome (RDS)Shock
Beyond the preview
Go deeper on NCT02000674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02000674.